| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anti-Bacterial Agents | 18 | 2020 | 143 | 3.750 |
Why?
|
| Drug Utilization | 16 | 2018 | 121 | 2.240 |
Why?
|
| Appendicitis | 3 | 2024 | 14 | 1.830 |
Why?
|
| Parents | 12 | 2018 | 297 | 1.820 |
Why?
|
| Asthma | 23 | 2010 | 400 | 1.810 |
Why?
|
| Child | 52 | 2024 | 2403 | 1.780 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2018 | 367 | 1.740 |
Why?
|
| Practice Patterns, Physicians' | 15 | 2018 | 302 | 1.670 |
Why?
|
| Diabetic Ketoacidosis | 2 | 2023 | 6 | 1.630 |
Why?
|
| Sepsis | 3 | 2023 | 65 | 1.610 |
Why?
|
| Child, Preschool | 40 | 2020 | 1380 | 1.460 |
Why?
|
| Respiratory Tract Infections | 5 | 2016 | 51 | 1.160 |
Why?
|
| Chronic Disease | 7 | 2018 | 397 | 1.080 |
Why?
|
| Adolescent | 33 | 2023 | 3538 | 1.050 |
Why?
|
| Humans | 58 | 2024 | 17314 | 0.960 |
Why?
|
| Infant | 17 | 2018 | 1161 | 0.950 |
Why?
|
| Medicaid | 13 | 2018 | 189 | 0.840 |
Why?
|
| Male | 42 | 2018 | 9804 | 0.840 |
Why?
|
| Physicians | 3 | 2018 | 117 | 0.810 |
Why?
|
| Massachusetts | 13 | 2017 | 60 | 0.780 |
Why?
|
| Health Education | 5 | 2008 | 82 | 0.770 |
Why?
|
| Female | 43 | 2018 | 12396 | 0.760 |
Why?
|
| Pneumococcal Infections | 3 | 2011 | 44 | 0.700 |
Why?
|
| Attitude of Health Personnel | 5 | 2018 | 197 | 0.690 |
Why?
|
| Anti-Asthmatic Agents | 8 | 2005 | 89 | 0.690 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2012 | 64 | 0.660 |
Why?
|
| Emergency Service, Hospital | 4 | 2023 | 384 | 0.660 |
Why?
|
| Quality of Health Care | 4 | 2018 | 259 | 0.640 |
Why?
|
| United States | 26 | 2018 | 3866 | 0.630 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 452 | 0.600 |
Why?
|
| Managed Care Programs | 13 | 2008 | 300 | 0.570 |
Why?
|
| Crohn Disease | 2 | 2007 | 12 | 0.550 |
Why?
|
| Inappropriate Prescribing | 2 | 2016 | 8 | 0.550 |
Why?
|
| Transition to Adult Care | 1 | 2017 | 11 | 0.540 |
Why?
|
| Medication Reconciliation | 1 | 2017 | 6 | 0.540 |
Why?
|
| Pediatric Obesity | 1 | 2018 | 88 | 0.530 |
Why?
|
| Critical Care | 1 | 2017 | 66 | 0.510 |
Why?
|
| Ambulatory Care | 3 | 2016 | 225 | 0.500 |
Why?
|
| Insurance, Health | 4 | 2014 | 170 | 0.500 |
Why?
|
| Patient Readmission | 1 | 2018 | 161 | 0.500 |
Why?
|
| Otitis Media | 4 | 2012 | 19 | 0.490 |
Why?
|
| Primary Health Care | 6 | 2010 | 726 | 0.490 |
Why?
|
| Adult | 15 | 2023 | 7500 | 0.480 |
Why?
|
| Multivariate Analysis | 8 | 2017 | 535 | 0.440 |
Why?
|
| Retrospective Studies | 8 | 2023 | 2415 | 0.440 |
Why?
|
| Cross-Sectional Studies | 8 | 2023 | 1280 | 0.430 |
Why?
|
| Infant, Newborn | 6 | 2018 | 805 | 0.430 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2013 | 16 | 0.420 |
Why?
|
| Delayed Diagnosis | 2 | 2023 | 21 | 0.400 |
Why?
|
| Pneumococcal Vaccines | 3 | 2009 | 68 | 0.400 |
Why?
|
| Hospitals, Pediatric | 3 | 2023 | 71 | 0.380 |
Why?
|
| Pediatrics | 7 | 2014 | 142 | 0.380 |
Why?
|
| Central Nervous System Stimulants | 1 | 2012 | 26 | 0.380 |
Why?
|
| Young Adult | 5 | 2023 | 2465 | 0.370 |
Why?
|
| Streptococcus pneumoniae | 1 | 2011 | 21 | 0.360 |
Why?
|
| Models, Economic | 1 | 2011 | 17 | 0.350 |
Why?
|
| Health Care Surveys | 6 | 2017 | 211 | 0.340 |
Why?
|
| Health Services Accessibility | 4 | 2010 | 271 | 0.330 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2009 | 8 | 0.320 |
Why?
|
| Carrier State | 1 | 2009 | 8 | 0.320 |
Why?
|
| Staphylococcal Infections | 1 | 2009 | 16 | 0.310 |
Why?
|
| Delivery of Health Care | 2 | 2011 | 390 | 0.310 |
Why?
|
| Medication Adherence | 1 | 2012 | 235 | 0.310 |
Why?
|
| Patient Education as Topic | 2 | 2008 | 193 | 0.310 |
Why?
|
| Drug Resistance, Microbial | 1 | 2008 | 4 | 0.280 |
Why?
|
| Logistic Models | 6 | 2010 | 879 | 0.280 |
Why?
|
| Prospective Studies | 5 | 2017 | 1226 | 0.280 |
Why?
|
| Case Management | 2 | 2005 | 29 | 0.280 |
Why?
|
| Colitis, Ulcerative | 1 | 2007 | 8 | 0.280 |
Why?
|
| Pharyngitis | 2 | 2016 | 10 | 0.280 |
Why?
|
| Gastrointestinal Agents | 1 | 2007 | 3 | 0.270 |
Why?
|
| Overweight | 2 | 2020 | 266 | 0.270 |
Why?
|
| Data Collection | 4 | 2014 | 238 | 0.260 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2004 | 27 | 0.260 |
Why?
|
| Hospital Charges | 1 | 2006 | 7 | 0.250 |
Why?
|
| Quality Assurance, Health Care | 2 | 2008 | 124 | 0.250 |
Why?
|
| Focus Groups | 2 | 2018 | 143 | 0.250 |
Why?
|
| Streptococcus pyogenes | 1 | 2005 | 6 | 0.240 |
Why?
|
| Attitude to Health | 2 | 2005 | 147 | 0.240 |
Why?
|
| Streptococcal Infections | 1 | 2005 | 22 | 0.240 |
Why?
|
| Outcome and Process Assessment (Health Care) | 2 | 2004 | 97 | 0.240 |
Why?
|
| Hospitalization | 5 | 2007 | 804 | 0.230 |
Why?
|
| Drug Prescriptions | 4 | 2008 | 146 | 0.230 |
Why?
|
| Macrolides | 1 | 2004 | 6 | 0.230 |
Why?
|
| Cluster Analysis | 4 | 2009 | 86 | 0.220 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2005 | 215 | 0.220 |
Why?
|
| Middle Aged | 8 | 2018 | 7836 | 0.220 |
Why?
|
| Otitis | 1 | 2003 | 1 | 0.210 |
Why?
|
| Area Under Curve | 1 | 2023 | 33 | 0.200 |
Why?
|
| Severity of Illness Index | 5 | 2010 | 437 | 0.200 |
Why?
|
| Family Practice | 4 | 2008 | 40 | 0.200 |
Why?
|
| Total Quality Management | 1 | 2002 | 18 | 0.190 |
Why?
|
| Air Pollution, Indoor | 1 | 2002 | 7 | 0.190 |
Why?
|
| Risk Factors | 5 | 2011 | 3258 | 0.180 |
Why?
|
| Environmental Exposure | 1 | 2002 | 121 | 0.180 |
Why?
|
| Incidence | 4 | 2011 | 1266 | 0.170 |
Why?
|
| Age Distribution | 3 | 2018 | 239 | 0.170 |
Why?
|
| Interviews as Topic | 2 | 2018 | 306 | 0.150 |
Why?
|
| Prevalence | 3 | 2016 | 840 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 33 | 0.150 |
Why?
|
| Risk Assessment | 4 | 2008 | 1076 | 0.150 |
Why?
|
| Hospitals, High-Volume | 1 | 2018 | 2 | 0.150 |
Why?
|
| Risk | 2 | 2018 | 496 | 0.140 |
Why?
|
| New York | 1 | 2018 | 17 | 0.140 |
Why?
|
| Maryland | 1 | 2018 | 17 | 0.140 |
Why?
|
| Confidence Intervals | 4 | 2008 | 231 | 0.140 |
Why?
|
| Urban Population | 1 | 2018 | 109 | 0.140 |
Why?
|
| Near Miss, Healthcare | 1 | 2017 | 1 | 0.140 |
Why?
|
| Medication Errors | 1 | 2017 | 6 | 0.130 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 6 | 0.130 |
Why?
|
| Odds Ratio | 4 | 2008 | 640 | 0.130 |
Why?
|
| Otitis Media, Suppurative | 1 | 2016 | 1 | 0.130 |
Why?
|
| Time Factors | 2 | 2018 | 1039 | 0.130 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 186 | 0.120 |
Why?
|
| Models, Statistical | 1 | 2017 | 170 | 0.120 |
Why?
|
| Health Services | 2 | 2007 | 110 | 0.120 |
Why?
|
| Cohort Studies | 8 | 2018 | 2514 | 0.120 |
Why?
|
| Education, Medical, Continuing | 2 | 2005 | 31 | 0.110 |
Why?
|
| Age Factors | 3 | 2008 | 878 | 0.110 |
Why?
|
| Computer Communication Networks | 1 | 2014 | 9 | 0.110 |
Why?
|
| Midwestern United States | 1 | 2014 | 3 | 0.110 |
Why?
|
| New England | 1 | 2014 | 12 | 0.110 |
Why?
|
| Northwestern United States | 1 | 2014 | 53 | 0.110 |
Why?
|
| Medicine, Traditional | 1 | 2013 | 3 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2005 | 66 | 0.110 |
Why?
|
| Aged | 4 | 2016 | 6084 | 0.110 |
Why?
|
| Watchful Waiting | 1 | 2013 | 22 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2012 | 9 | 0.100 |
Why?
|
| Influenza Vaccines | 2 | 2006 | 292 | 0.100 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 163 | 0.100 |
Why?
|
| Educational Status | 2 | 2003 | 177 | 0.100 |
Why?
|
| Continental Population Groups | 2 | 2006 | 286 | 0.100 |
Why?
|
| Socioeconomic Factors | 3 | 2010 | 605 | 0.090 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 2 | 2009 | 15 | 0.090 |
Why?
|
| Office Visits | 3 | 2008 | 73 | 0.090 |
Why?
|
| Probability | 2 | 2008 | 71 | 0.090 |
Why?
|
| Sinusitis | 1 | 2011 | 18 | 0.090 |
Why?
|
| Group Practice | 2 | 2008 | 21 | 0.080 |
Why?
|
| Inpatients | 1 | 2011 | 79 | 0.080 |
Why?
|
| Outpatients | 1 | 2011 | 101 | 0.080 |
Why?
|
| Nasal Cavity | 1 | 2009 | 2 | 0.080 |
Why?
|
| Regression Analysis | 2 | 2007 | 270 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2008 | 1151 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2011 | 207 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2010 | 104 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2014 | 704 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 191 | 0.070 |
Why?
|
| Acute Disease | 2 | 2008 | 144 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 28 | 0.070 |
Why?
|
| Amoxicillin | 1 | 2008 | 3 | 0.070 |
Why?
|
| Treatment Failure | 1 | 2008 | 31 | 0.070 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 70 | 0.070 |
Why?
|
| Reference Values | 1 | 2008 | 87 | 0.070 |
Why?
|
| Health Maintenance Organizations | 3 | 2006 | 407 | 0.070 |
Why?
|
| Mesalamine | 1 | 2007 | 1 | 0.070 |
Why?
|
| Prednisolone | 1 | 2007 | 4 | 0.070 |
Why?
|
| Infliximab | 1 | 2007 | 6 | 0.070 |
Why?
|
| Canada | 1 | 2007 | 70 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 25 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2007 | 30 | 0.070 |
Why?
|
| Qualitative Research | 1 | 2008 | 260 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2006 | 310 | 0.060 |
Why?
|
| Teratogens | 1 | 2006 | 3 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2008 | 342 | 0.060 |
Why?
|
| Drug Therapy | 1 | 2006 | 16 | 0.060 |
Why?
|
| Mass Media | 1 | 2006 | 15 | 0.060 |
Why?
|
| Hospitals, Teaching | 1 | 2006 | 17 | 0.060 |
Why?
|
| Sex Factors | 1 | 2008 | 603 | 0.060 |
Why?
|
| Influenza, Human | 2 | 2006 | 282 | 0.060 |
Why?
|
| Surveys and Questionnaires | 3 | 2006 | 1282 | 0.060 |
Why?
|
| Policy Making | 1 | 2005 | 13 | 0.060 |
Why?
|
| Peer Group | 1 | 2005 | 54 | 0.060 |
Why?
|
| Personal Satisfaction | 1 | 2005 | 12 | 0.060 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2005 | 4 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2005 | 43 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2005 | 19 | 0.060 |
Why?
|
| Culture | 1 | 2005 | 30 | 0.060 |
Why?
|
| Registries | 1 | 2007 | 460 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2020 | 937 | 0.060 |
Why?
|
| Health Surveys | 1 | 2005 | 245 | 0.060 |
Why?
|
| Physicians, Family | 1 | 2004 | 36 | 0.060 |
Why?
|
| Cultural Diversity | 1 | 2004 | 17 | 0.060 |
Why?
|
| Mothers | 1 | 2005 | 103 | 0.050 |
Why?
|
| Vaccines, Conjugate | 1 | 2004 | 59 | 0.050 |
Why?
|
| Immunization Programs | 1 | 2004 | 65 | 0.050 |
Why?
|
| Meningococcal Vaccines | 1 | 2004 | 39 | 0.050 |
Why?
|
| Research Design | 2 | 2004 | 336 | 0.050 |
Why?
|
| Process Assessment (Health Care) | 1 | 2003 | 23 | 0.050 |
Why?
|
| Decision Making | 1 | 2005 | 171 | 0.050 |
Why?
|
| Vaccination | 2 | 2006 | 688 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2003 | 139 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2004 | 149 | 0.050 |
Why?
|
| Ethnic Groups | 2 | 2006 | 451 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2003 | 92 | 0.050 |
Why?
|
| Linear Models | 1 | 2003 | 206 | 0.050 |
Why?
|
| Chicago | 1 | 2002 | 25 | 0.050 |
Why?
|
| Boston | 1 | 2002 | 28 | 0.050 |
Why?
|
| Efficiency, Organizational | 1 | 2002 | 26 | 0.050 |
Why?
|
| Minority Groups | 1 | 2002 | 104 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 381 | 0.050 |
Why?
|
| Community Health Centers | 1 | 2002 | 64 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2002 | 205 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 298 | 0.040 |
Why?
|
| Pregnancy | 1 | 2006 | 1463 | 0.040 |
Why?
|
| Washington | 1 | 2002 | 384 | 0.040 |
Why?
|
| Child Health Services | 1 | 2002 | 105 | 0.040 |
Why?
|
| Health Behavior | 1 | 2003 | 346 | 0.040 |
Why?
|
| Patient Selection | 1 | 2002 | 176 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2003 | 277 | 0.040 |
Why?
|
| Prescriptions | 1 | 2020 | 29 | 0.040 |
Why?
|
| Mass Screening | 1 | 2006 | 672 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 664 | 0.040 |
Why?
|
| Body Height | 1 | 2018 | 60 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2008 | 1160 | 0.030 |
Why?
|
| Body Weight | 1 | 2018 | 203 | 0.030 |
Why?
|
| Steroids | 2 | 2007 | 12 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2007 | 82 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 674 | 0.030 |
Why?
|
| Vocabulary, Controlled | 1 | 2014 | 1 | 0.030 |
Why?
|
| Obesity | 1 | 2020 | 814 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2014 | 36 | 0.030 |
Why?
|
| State Health Plans | 2 | 2004 | 32 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2014 | 50 | 0.030 |
Why?
|
| Administration, Inhalation | 2 | 2004 | 40 | 0.030 |
Why?
|
| Poverty | 2 | 2003 | 168 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2008 | 17 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 99 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 120 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2008 | 180 | 0.020 |
Why?
|
| Recurrence | 1 | 2008 | 165 | 0.020 |
Why?
|
| Health Policy | 1 | 2008 | 109 | 0.020 |
Why?
|
| Health Services Administration | 1 | 2007 | 3 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2007 | 48 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 107 | 0.020 |
Why?
|
| Caregivers | 1 | 2007 | 128 | 0.020 |
Why?
|
| Korea | 1 | 2005 | 9 | 0.010 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2005 | 16 | 0.010 |
Why?
|
| Child Welfare | 1 | 2004 | 40 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2004 | 59 | 0.010 |
Why?
|
| Poisson Distribution | 1 | 2004 | 85 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 226 | 0.010 |
Why?
|
| Utilization Review | 1 | 2004 | 42 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2006 | 314 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2004 | 33 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 146 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2004 | 90 | 0.010 |
Why?
|
| Vulnerable Populations | 1 | 2003 | 34 | 0.010 |
Why?
|
| Health Services Research | 1 | 2004 | 202 | 0.010 |
Why?
|
| Disease Management | 1 | 2003 | 111 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2002 | 13 | 0.010 |
Why?
|
| Private Practice | 1 | 2002 | 5 | 0.010 |
Why?
|
| Fee-for-Service Plans | 1 | 2002 | 21 | 0.010 |
Why?
|
| Communication | 1 | 2003 | 178 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2002 | 125 | 0.010 |
Why?
|
| Health Status | 1 | 2002 | 293 | 0.010 |
Why?
|
| Hispanic Americans | 1 | 2002 | 375 | 0.010 |
Why?
|
| European Continental Ancestry Group | 1 | 2002 | 476 | 0.010 |
Why?
|
| African Americans | 1 | 2002 | 439 | 0.010 |
Why?
|